These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 25916224)
21. The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases. Farkas K; Saródi Z; Bálint A; Földesi I; Tiszlavicz L; Szűcs M; Nyári T; Tajti J; Nagy F; Szepes Z; Bor R; Annaházi A; Róka R; Molnár T J Crohns Colitis; 2015 Mar; 9(3):231-7. PubMed ID: 25585596 [TBL] [Abstract][Full Text] [Related]
22. Effect of probiotics (Lactobacillus plantarum 299 plus Bifidobacterium Cure21) in patients with poor ileal pouch function: a randomised controlled trial. Bengtsson J; Adlerberth I; Östblom A; Saksena P; Öresland T; Börjesson L Scand J Gastroenterol; 2016 Sep; 51(9):1087-92. PubMed ID: 27150635 [TBL] [Abstract][Full Text] [Related]
23. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch. Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628 [TBL] [Abstract][Full Text] [Related]
24. Laboratory tests for patients with ileal pouch-anal anastomosis: clinical utility in predicting, diagnosing, and monitoring pouch disorders. Navaneethan U; Shen B Am J Gastroenterol; 2009 Oct; 104(10):2606-15. PubMed ID: 19603012 [TBL] [Abstract][Full Text] [Related]
25. Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis. Laake KO; Line PD; Aabakken L; Løtveit T; Bakka A; Eide J; Roseth A; Grzyb K; Bjørneklett A; Vatn MH Scand J Gastroenterol; 2003 Apr; 38(4):409-14. PubMed ID: 12739713 [TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitis. Mäkitalo L; Piekkala M; Ashorn M; Pakarinen M; Koivusalo A; Karikoski R; Natunen J; Saarialho-Kere U; Rintala R; Kolho KL World J Gastroenterol; 2012 Aug; 18(30):4028-36. PubMed ID: 22912554 [TBL] [Abstract][Full Text] [Related]
27. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial. Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351 [TBL] [Abstract][Full Text] [Related]
28. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Parsi MA; Shen B; Achkar JP; Remzi FF; Goldblum JR; Boone J; Lin D; Connor JT; Fazio VW; Lashner BA Gastroenterology; 2004 May; 126(5):1280-6. PubMed ID: 15131788 [TBL] [Abstract][Full Text] [Related]
29. The assessment of a rapid noninvasive immunochromatographic assay test for fecal lactoferrin in patients with suspected inflammation of the ileal pouch. Lim M; Gonsalves S; Thekkinkattil D; Seedat S; Finan P; Sagar P; Burke D Dis Colon Rectum; 2008 Jan; 51(1):96-9. PubMed ID: 18085334 [TBL] [Abstract][Full Text] [Related]
30. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108 [TBL] [Abstract][Full Text] [Related]
31. Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy. De Vos M; Louis EJ; Jahnsen J; Vandervoort JG; Noman M; Dewit O; Dʼhaens GR; Franchimont D; Baert FJ; Torp RA; Henriksen M; Potvin PM; Van Hootegem PP; Hindryckx PM; Moreels TG; Collard A; Karlsen LN; Kittang E; Lambrecht G; Grimstad T; Koch J; Lygren I; Coche JC; Mana F; Van Gossum A; Belaiche J; Cool MR; Fontaine F; Maisin JM; Muls V; Neuville B; Staessen DA; Van Assche GA; de Lange T; Solberg IC; Vander Cruyssen BJ; Vermeire SA Inflamm Bowel Dis; 2013 Sep; 19(10):2111-7. PubMed ID: 23883959 [TBL] [Abstract][Full Text] [Related]
32. Fecal markers: calprotectin and lactoferrin. Abraham BP; Kane S Gastroenterol Clin North Am; 2012 Jun; 41(2):483-95. PubMed ID: 22500530 [TBL] [Abstract][Full Text] [Related]
33. Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. Madiba TE; Bartolo DC J R Coll Surg Edinb; 2001 Dec; 46(6):334-7. PubMed ID: 11768572 [TBL] [Abstract][Full Text] [Related]
34. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy. Bar-Gil Shitrit A; Koslowsky B; Livovsky DM; Shitrit D; Paz K; Adar T; Adler SN; Goldin E Scand J Gastroenterol; 2017 Mar; 52(3):328-333. PubMed ID: 27841040 [TBL] [Abstract][Full Text] [Related]
35. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease. Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672 [TBL] [Abstract][Full Text] [Related]
36. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. Singh S; Ananthakrishnan AN; Nguyen NH; Cohen BL; Velayos FS; Weiss JM; Sultan S; Siddique SM; Adler J; Chachu KA; Gastroenterology; 2023 Mar; 164(3):344-372. PubMed ID: 36822736 [TBL] [Abstract][Full Text] [Related]
37. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis. Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374 [TBL] [Abstract][Full Text] [Related]
38. Pouchitis and pre-pouch ileitis developed after restorative proctocolectomy for ulcerative colitis: a case report. Iwata T; Yamamoto T; Umegae S; Matsumoto K World J Gastroenterol; 2007 Jan; 13(4):643-6. PubMed ID: 17278237 [TBL] [Abstract][Full Text] [Related]
39. Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Machiels K; Sabino J; Vandermosten L; Joossens M; Arijs I; de Bruyn M; Eeckhaut V; Van Assche G; Ferrante M; Verhaegen J; Van Steen K; Van Immerseel F; Huys G; Verbeke K; Wolthuis A; de Buck Van Overstraeten A; D'Hoore A; Rutgeerts P; Vermeire S Gut; 2017 Jan; 66(1):79-88. PubMed ID: 26423113 [TBL] [Abstract][Full Text] [Related]
40. Fecal lactoferrin: a noninvasive fecal biomarker for the diagnosis and surveillance of pouchitis. Gonsalves S; Lim M; Finan P; Sagar P; Burke D Dis Colon Rectum; 2013 Jun; 56(6):733-7. PubMed ID: 23652747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]